Crucial storage executive diagnostic iso#

The MRU works closely with other parts of the UK Health Security Agency ( UKHSA), particularly the Immunisation and Countermeasures Department based at Colindale, to optimise meningococcal disease ascertainment through enhanced surveillance, often with direct communication with UKHSA Health Protection teams.Īccredited to ISO 15189, the MRU has been a world leader in developing and making nationally available tests for non-culture case confirmation of meningococcal infection by PCR. The MMMP is part of the recently established Manchester University NHS Foundation Trust ( MFT), formerly Central Manchester Foundation Trust ( CMFT). The MRU is located at the Manchester Royal Infirmary ( MRI) and is an integral component of the Manchester Medical Microbiology Partnership ( MMMP). Originally established to provide phenotypic characterisation of meningococci isolated from cases of invasive meningococcal disease ( IMD) throughout the country, the nature and scope of the confirmation and surveillance activity has widened, as has the range of tests available. The Meningococcal Reference Unit ( MRU) for England and Wales and Northern Ireland (NI) has been situated in Manchester since 1978. meningococcal serology including vaccine response (performed by the Vaccine Evaluation Unit ( VEU))Īuthorised By: Professor Ray Borrow (Head of Meningococcal Reference Unit)Įffective date: August 2023 Introduction Meningococcal Reference Unit overview.meningococcal (and Streptococcus pneumoniae) DNA detection and meningococcal capsular grouping by real-time polymerase chain reaction ( PCR).Capsular polysaccharide antigen detection (serogrouping).Neisseria meningitidis (meningococcal) isolate characterisation.This document contains information on reference services for:

Crucial storage executive diagnostic